Home > Riviste > Giornale Italiano di Dermatologia e Venereologia > Fascicoli precedenti > Giornale Italiano di Dermatologia e Venereologia 2019 October;154(5) > Giornale Italiano di Dermatologia e Venereologia 2019 October;154(5):586-8

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Per citare questo articolo

 

CASE REPORT   

Giornale Italiano di Dermatologia e Venereologia 2019 October;154(5):586-8

DOI: 10.23736/S0392-0488.16.05271-8

Copyright © 2015 EDIZIONI MINERVA MEDICA

lingua: Inglese

Ingenol mebutate for pigmented superficial basal cell carcinomas: evaluation by confocal microscopy

Giuseppe MONFRECOLA, Massimiliano SCALVENZI, Claudia COSTA, Mariateresa CANTELLI , Gabriella FABBROCINI

Unit of Dermatology, Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy


PDF


The incidence of nonmelanoma skin cancer continues to increase. Surgical excision remains the best choice of treatment but the demand of patients is to have tissue-sparing approaches with good cosmetic results; these aims led to the development of novel therapeutic agents such as topical ingenol mebutate gel. We report the successful treatment with ingenol mebutate gel 0.05% of three pigmented basal cell carcinomas. Lesions were evaluated by dermoscopy and confocal microscopy before, during and after the treatment.


KEY WORDS: 3-ingenyl angelate; Carcinoma, basal cell; Dermoscopy; Microscopy, confocal

inizio pagina